Portfolio (Quarterly)
Guide ↗
RTW INVESTMENTS, LP
· CIK 0001493215| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | ALKS | ALKERMES PLC | Healthcare | 1,672,356.0 | $59.1M | 0.59% | — | — | $35.36 | +25.9% |
| 42 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 10,632,390.0 | $58.8M | 0.58% | +1.9M | +21.4% | $5.53 | +115.9% |
| 43 | KOD | KODIAK SCIENCES INC | Healthcare | 1,487,934.0 | $56.7M | 0.56% | — | — | $38.12 | -6.3% |
| 44 | REPL | REPLIMUNE GROUP INC | Healthcare | 7,356,916.0 | $56.3M | 0.56% | +217K | +3.0% | $7.65 | +30.7% |
| 45 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 1,451,326.0 | $52.7M | 0.53% | +100K | +7.4% | $36.32 | -1.6% |
| 46 | QURE | UNIQURE NV | Healthcare | 2,586,356.0 | $42.3M | 0.42% | -1.1M | -30.3% | $16.35 | +194.6% |
| 47 | WAY | WAYSTAR HLDG CORP | Technology | 1,630,000.0 | $39.3M | 0.39% | NEW | — | $24.11 | -24.3% |
| 48 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 585,682.0 | $36.7M | 0.36% | — | — | $62.70 | +29.3% |
| 49 | OBIO | ORCHESTRA BIOMED HLDGS INC | Healthcare | 8,306,063.0 | $35.3M | 0.35% | — | — | $4.25 | -8.9% |
| 50 | — | VERASTEM INC | — | 6,576,306.0 | $34.9M | 0.35% | — | — | $5.30 | — |
| 51 | EVMN | EVOMMUNE INC | Healthcare | 1,502,235.0 | $34.5M | 0.34% | +219K | +17.0% | $22.99 | -10.1% |
| 52 | SYK | STRYKER CORPORATION | Healthcare | 100,000.0 | $32.9M | 0.33% | -145K | -59.2% | $328.59 | -8.4% |
| 53 | SVRA | SAVARA INC | Healthcare | 5,952,380.0 | $32.5M | 0.32% | — | — | $5.46 | -1.5% |
| 54 | CADL | CANDEL THERAPEUTICS INC | Healthcare | 6,422,018.0 | $31.5M | 0.31% | NEW | — | $4.90 | +63.1% |
| 55 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 7,426,471.0 | $30.8M | 0.31% | +1.2M | +18.8% | $4.15 | +6.7% |
| 56 | AKTS | AKTIS ONCOLOGY INC | Healthcare | 1,592,043.0 | $28.5M | 0.28% | NEW | — | $17.89 | +31.5% |
| 57 | NGNE | NEUROGENE INC | Healthcare | 1,362,456.0 | $27.5M | 0.27% | — | — | $20.16 | +52.7% |
| 58 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 1,705,960.0 | $24.2M | 0.24% | — | — | $14.21 | +1.6% |
| 59 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 4,186,599.0 | $22.1M | 0.22% | +1.7M | +67.5% | $5.29 | -61.2% |
| 60 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 248,063.0 | $20.8M | 0.21% | NEW | — | $83.92 | -2.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%